
Sign up to save your podcasts
Or
On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.
4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.
6,247 Listeners
696 Listeners
465 Listeners
926 Listeners
38,652 Listeners
44,047 Listeners
90,382 Listeners
38,049 Listeners
30,738 Listeners
32,140 Listeners
939 Listeners
43,879 Listeners
389 Listeners
2,127 Listeners
1,628 Listeners